<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>DIGIFab - Patient Education Opportunity</title>
<style>
body {
margin: 0;
padding: 0;
font-family: sans-serif;
display: flex;
align-items: center;
justify-content: center;
height: 600px;
}
.container {
width: 300px;
display: grid;
grid-template-columns: 1fr;
grid-template-rows: 70px auto 1fr;
align-items: start;
height: 100%;
padding: 10px;
box-sizing: border-box;
border: 1px solid #ccc;
}
.logo {
width: 100%;
height: auto;
margin-bottom: 10px;
}
.content {
display: flex;
flex-direction: column;
line-height: 1.2;
margin: 0;
padding: 0;
font-size: 12px;
}
.heading {
font-weight: bold;
margin: 0 0 5px 0;
color: #014757;
}
.subheading {
font-weight: bold;
margin: 0 0 5px 0;
}
.text {
margin: 0 0 5px 0;
}
.button {
background-color: #014757;
color: white;
padding: 5px 10px;
border: none;
border-radius: 5px;
cursor: pointer;
text-decoration: none;
text-align: center;
margin-top: 5px;
font-size: 12px;
white-space: nowrap;
overflow: hidden;
text-overflow: ellipsis;
}
.scrolling-box {
padding: 10px;
margin-top: 10px;
border: 1px solid #ccc;
height: 300px;
overflow-y: scroll;
font-size: 12px;
}
.scrolling-box p,
.scrolling-box ul {
margin: 0;
padding: 0;
}
.scrolling-box ul {
padding-left: 20px;
}
</style>
</head>
<body>
<div class="container">
<img class="logo" src="https://serb.com/wp-content/uploads/2022/09/SERB-logo-200x57-1.svg" alt="SERB Logo">
<div class="content">
<p class="heading">Patient Education Opportunity!</p>
<p class="subheading">Recognize Digoxin Toxicity</p>
<p class="text">This patient is on digoxin. Watch for toxicity due to drug interactions, organ function changes, or dehydration. Symptoms include nausea, vomiting, and arrhythmias. Click to Learn More:</p>
<a href="https://digifab.health/en-us/digoxin-toxicity/early-recognition.html" class="button">Early Recognition of Digoxin Toxicity | DIGIFab</a>
<p class="text">For full Prescribing Information, <a href="https://digifab.health/getmedia/f821face-fe6e-4105-8090-5b81816942f0/DigiFab-PI_P12011E_A4-Updated-June2017.pdf">click here</a></p>
<p class="text" align="right"><small>US-DGF-2400033</small></p>
</div>
<div class="scrolling-box">
<p><strong>INDICATIONS AND USAGE</strong></p>
<p>DIGIFab is indicated for the treatment of patients with life-threatening or potentially life-threatening digoxin toxicity or overdose, including:</p>
<ul>
<li>Known suicidal or accidental consumption of fatal doses of digoxin: 10 mg or more of digoxin in healthy adults, or 4 mg (or more than 0.1 mg/kg) in healthy children, or ingestion of an amount that can cause steady state serum concentrations of ≥10 ng/mL;</li>
<li>Chronic ingestions causing steady-state serum digoxin concentrations >6 ng/mL in adults or 4 ng/mL in children;</li>
<li>Manifestations of life-threatening toxicity of digoxin overdose such as severe ventricular arrhythmias, progressive bradycardia, and second or third degree
2
2
4KB
12KB
63.0ms
88.0ms
147.0ms